Skip to main content
Erschienen in: Journal of Nanoparticle Research 9/2018

01.09.2018 | Research Paper

Hyaluronic acid-coated liposome for active targeting on CD44 expressing tumors

verfasst von: Zhenfen Tian, Jianwen Liu, Na Li, Vasil M. Garamus, Aihua Zou

Erschienen in: Journal of Nanoparticle Research | Ausgabe 9/2018

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config
loading …

Abstract

Liposome coated with hyaluronic acid (HA) was fabricated for targeted delivery of Doxorubicin hydrochloride (DOX) to CD44 expressing tumors. DOX was incorporated into liposome (DOX-L) via a transmembrane pH-gradient method, which contributed to high encapsulation efficiency (97%) and drug loading (19%). HA was modified on the surface of DOX-L by simple vortex (HA-DOX-L). The average diameter of optimized DOX-L and H-DOX-L was 109.7 ± 3.1 and 117.2 ± 5.0 nm, respectively, with good uniformity and stability during 6-month storage. SAXS and TEM evidenced the corona of HA on the surface of DOX-L, which convinced the prolonged circulation of DOX. The apoptosis study demonstrated the improved efficacy of HA-DOX-L with the human colon cancer cell line HCT-116 cells in comparison to the conventional reservoirs. This improved efficacy of HA-DOX-L with HCT-116 cells should be related with the interaction between HA and CD44 receptor of HCT-116 cells.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Anabousi S, Laue M, Lehr CM, Bakowsky U, Ehrhardt C (2005) Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. Eur J Pharm Biopharm 60:295–303CrossRef Anabousi S, Laue M, Lehr CM, Bakowsky U, Ehrhardt C (2005) Assessing transferrin modification of liposomes by atomic force microscopy and transmission electron microscopy. Eur J Pharm Biopharm 60:295–303CrossRef
Zurück zum Zitat Andresen TL, Jensen SS, Gensen KJ (2005) Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44:68–97CrossRef Andresen TL, Jensen SS, Gensen KJ (2005) Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44:68–97CrossRef
Zurück zum Zitat Angelova A, Fajolles C, Hocquelet C, Djedaïni-Pilard F, Lesieur S, Bonnet V, Perly B, Lebas G, Mauclaire L (2008) Physico-chemical investigation of asymmetrical peptidolipidyl-cyclodextrins. J Colloid Interface Sci 322:304–314CrossRef Angelova A, Fajolles C, Hocquelet C, Djedaïni-Pilard F, Lesieur S, Bonnet V, Perly B, Lebas G, Mauclaire L (2008) Physico-chemical investigation of asymmetrical peptidolipidyl-cyclodextrins. J Colloid Interface Sci 322:304–314CrossRef
Zurück zum Zitat Bourguignon LYW, Singleton PA, Zhu HB, Zhou B (2002) Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem 277:39703–39712CrossRef Bourguignon LYW, Singleton PA, Zhu HB, Zhou B (2002) Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem 277:39703–39712CrossRef
Zurück zum Zitat Chen YY, Angelova A, Angelov B, Drechsler M, Garamus VM, Willumeit-RÖmere R, Zou AH (2015) Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines. J Mater Chem B 3:7734–7744CrossRef Chen YY, Angelova A, Angelov B, Drechsler M, Garamus VM, Willumeit-RÖmere R, Zou AH (2015) Sterically stabilized spongosomes for multidrug delivery of anticancer nanomedicines. J Mater Chem B 3:7734–7744CrossRef
Zurück zum Zitat Csoka AB, Frost GI, Stern R (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20:499–508CrossRef Csoka AB, Frost GI, Stern R (2001) The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol 20:499–508CrossRef
Zurück zum Zitat Cullis PR, Bally MB, Madden TD, Mayer LD, Hope MJ (1991) pH gradients and membrane transport in liposomal systems. Trends Biotechnol 9:268–272CrossRef Cullis PR, Bally MB, Madden TD, Mayer LD, Hope MJ (1991) pH gradients and membrane transport in liposomal systems. Trends Biotechnol 9:268–272CrossRef
Zurück zum Zitat Dong J, Jiang DH, Wang Z, Wu GZ, Miao LY, Huang LX (2013) Intra-articular delivery of liposomal celecoxib–hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 441:285–290CrossRef Dong J, Jiang DH, Wang Z, Wu GZ, Miao LY, Huang LX (2013) Intra-articular delivery of liposomal celecoxib–hyaluronate combination for the treatment of osteoarthritis in rabbit model. Int J Pharm 441:285–290CrossRef
Zurück zum Zitat Fan YC, Du WW, He B, Fu FY, Yuan L, Wu HN, Dai WB, Zhang H, Wang XQ, Wang JC, Zhang X, Zhang Q (2013) The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin. Biomaterial 34:2277–2288CrossRef Fan YC, Du WW, He B, Fu FY, Yuan L, Wu HN, Dai WB, Zhang H, Wang XQ, Wang JC, Zhang X, Zhang Q (2013) The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin. Biomaterial 34:2277–2288CrossRef
Zurück zum Zitat Ferrer-Tasies L, Moreno-Calvo E, Cano-Sarabia M, Aguilella-Arzo M, Angelova A, Lesieur S, Ricart S, Faraudo J, Ventosa N, Veciana J (2013) Quatsomes: vesicles formed by self-assembly of sterols and quaternary ammonium surfactants. Langmuir 29:6519–6528CrossRef Ferrer-Tasies L, Moreno-Calvo E, Cano-Sarabia M, Aguilella-Arzo M, Angelova A, Lesieur S, Ricart S, Faraudo J, Ventosa N, Veciana J (2013) Quatsomes: vesicles formed by self-assembly of sterols and quaternary ammonium surfactants. Langmuir 29:6519–6528CrossRef
Zurück zum Zitat Guo GN, Liu W, Liang JG, He ZK, Xu HB, Yang XL (2007) Probing the cytotoxicity of CdSe quantum dots with surface modification. Mater Lett 61:1641–1644CrossRef Guo GN, Liu W, Liang JG, He ZK, Xu HB, Yang XL (2007) Probing the cytotoxicity of CdSe quantum dots with surface modification. Mater Lett 61:1641–1644CrossRef
Zurück zum Zitat Hayashi K, Tatsui T, Shimanouchi T, Umakoshi H (2013) Enhanced cytotoxicity for Colon 26 cells using doxorubicin-loaded Sorbitan Monooleate (span 80) vesicles. Int J Biol Sci 9:142–148CrossRef Hayashi K, Tatsui T, Shimanouchi T, Umakoshi H (2013) Enhanced cytotoxicity for Colon 26 cells using doxorubicin-loaded Sorbitan Monooleate (span 80) vesicles. Int J Biol Sci 9:142–148CrossRef
Zurück zum Zitat Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H (2018) Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol 113:40–48CrossRef Kaddah S, Khreich N, Kaddah F, Charcosset C, Greige-Gerges H (2018) Cholesterol modulates the liposome membrane fluidity and permeability for a hydrophilic molecule. Food Chem Toxicol 113:40–48CrossRef
Zurück zum Zitat Kim E, Yang J, Park J, Kim S, Kim NH, Yook JI, Suh JS, Haam S, Huh YM (2012) Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer. ACS Nano 6:8525–8535CrossRef Kim E, Yang J, Park J, Kim S, Kim NH, Yook JI, Suh JS, Haam S, Huh YM (2012) Consecutive targetable smart nanoprobe for molecular recognition of cytoplasmic microRNA in metastatic breast cancer. ACS Nano 6:8525–8535CrossRef
Zurück zum Zitat Li F, Yang R, Weng Y, Tang X (2009) Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides. Drug Dev Ind Pharm 35:1048–1058CrossRef Li F, Yang R, Weng Y, Tang X (2009) Preparation and evaluation of lyophilized liposome-encapsulated bufadienolides. Drug Dev Ind Pharm 35:1048–1058CrossRef
Zurück zum Zitat Montero MT, MartÍ A, Hernàndez-Borrell J (1993) The active trapping of doxorubicin in liposomes by pH gradient: photon correlation spectroscopy and fluorimetric study. Int J Pharm 96:157–165CrossRef Montero MT, MartÍ A, Hernàndez-Borrell J (1993) The active trapping of doxorubicin in liposomes by pH gradient: photon correlation spectroscopy and fluorimetric study. Int J Pharm 96:157–165CrossRef
Zurück zum Zitat Nakamura K, Yoshino K, Yamashita K, Kasukawa H (2012) Designing a novel in vitro drug-release-testing method for liposomes prepared by pH-gradient method. Int J Pharm 430:381–387CrossRef Nakamura K, Yoshino K, Yamashita K, Kasukawa H (2012) Designing a novel in vitro drug-release-testing method for liposomes prepared by pH-gradient method. Int J Pharm 430:381–387CrossRef
Zurück zum Zitat Negi LM, Jaggi M, Joshi V, Ronodip K, Talegaonkar S (2015) Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer. Int J Biol Macromol 73:222–235CrossRef Negi LM, Jaggi M, Joshi V, Ronodip K, Talegaonkar S (2015) Hyaluronan coated liposomes as the intravenous platform for delivery of imatinib mesylate in MDR colon cancer. Int J Biol Macromol 73:222–235CrossRef
Zurück zum Zitat Nielsen SS, Toft KN, Snakenborg D, Jeppesen MG, Jacobsen JK, Vestergaard B, Kutter JP, Arleth L (2009) BioXTAS RAW, a software program for high-throughput automated small-angle X-ray scattering data reduction and preliminary analysis. J Appl Crystallogr 42:959–964CrossRef Nielsen SS, Toft KN, Snakenborg D, Jeppesen MG, Jacobsen JK, Vestergaard B, Kutter JP, Arleth L (2009) BioXTAS RAW, a software program for high-throughput automated small-angle X-ray scattering data reduction and preliminary analysis. J Appl Crystallogr 42:959–964CrossRef
Zurück zum Zitat Paliwal SR, Paliwal R, Agrawal GP, Vyas SP (2011) Liposomal nanomedicine for breast cancer therapy. Nanomedicine 6:1085–1100CrossRef Paliwal SR, Paliwal R, Agrawal GP, Vyas SP (2011) Liposomal nanomedicine for breast cancer therapy. Nanomedicine 6:1085–1100CrossRef
Zurück zum Zitat Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kimh K, Kwon IC, Kima DD (2014) Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release 174:98–108CrossRef Park JH, Cho HJ, Yoon HY, Yoon IS, Ko SH, Shim JS, Cho JH, Park JH, Kimh K, Kwon IC, Kima DD (2014) Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release 174:98–108CrossRef
Zurück zum Zitat Peer D, Margalit R (2004) Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6:343–353CrossRef Peer D, Margalit R (2004) Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 6:343–353CrossRef
Zurück zum Zitat Rahman YE, Cerny EA, Tollaksen SL, Wright BJ, Nance SL, Thomson JF (1974) Liposome-encapsulated actinomycin D: potential in cancer chemotherapy. Exp Biol Med 146:1173–1176CrossRef Rahman YE, Cerny EA, Tollaksen SL, Wright BJ, Nance SL, Thomson JF (1974) Liposome-encapsulated actinomycin D: potential in cancer chemotherapy. Exp Biol Med 146:1173–1176CrossRef
Zurück zum Zitat Silvia A, Carlotta L, Elisa DP, Chiara C, Nicolas T, Barbara S, Massimo D, Ilaria D, Elias F, Luigi C, Marta P (2013) Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 85:373–380CrossRef Silvia A, Carlotta L, Elisa DP, Chiara C, Nicolas T, Barbara S, Massimo D, Ilaria D, Elias F, Luigi C, Marta P (2013) Hyaluronic acid-coated liposomes for active targeting of gemcitabine. Eur J Pharm Biopharm 85:373–380CrossRef
Zurück zum Zitat Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539CrossRef Toole BP (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4:528–539CrossRef
Zurück zum Zitat Wu W, Zhang QJ, Wang JT, Chen M, Li S, Lin ZF, Li JS (2014) Tumor-targeted aggregation of pH-sensitive nanocarriers for enhanced retention and rapid intracellular drug release. Polym Chem 5:5668–5679CrossRef Wu W, Zhang QJ, Wang JT, Chen M, Li S, Lin ZF, Li JS (2014) Tumor-targeted aggregation of pH-sensitive nanocarriers for enhanced retention and rapid intracellular drug release. Polym Chem 5:5668–5679CrossRef
Zurück zum Zitat Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N (2013) Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett 334:338–345CrossRef Yang XY, Li YX, Li M, Zhang L, Feng LX, Zhang N (2013) Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett 334:338–345CrossRef
Zurück zum Zitat Zhang J, Chen XG, Li YY, Liu CS (2007) Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine 3:258–265CrossRef Zhang J, Chen XG, Li YY, Liu CS (2007) Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin. Nanomedicine 3:258–265CrossRef
Zurück zum Zitat Zhang WL, Wang GJ, Falconer JR, Baguley BC, Shaw JP, Liu JP, Xu HT, See E, Sun JG, Aa J, Wu ZM (2014) Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer. Drug Pharm Res 32:1451–1461CrossRef Zhang WL, Wang GJ, Falconer JR, Baguley BC, Shaw JP, Liu JP, Xu HT, See E, Sun JG, Aa J, Wu ZM (2014) Strategies to maximize liposomal drug loading for a poorly water-soluble anticancer. Drug Pharm Res 32:1451–1461CrossRef
Zurück zum Zitat Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254–267CrossRef Zöller M (2011) CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer 11:254–267CrossRef
Zurück zum Zitat Zong T, Ling M, Gao H, Wei C, Zhu P, Shi K, Chen J, Yang W, Gao F, Qin H (2014) Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm 11:2346–2357CrossRef Zong T, Ling M, Gao H, Wei C, Zhu P, Shi K, Chen J, Yang W, Gao F, Qin H (2014) Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals. Mol Pharm 11:2346–2357CrossRef
Metadaten
Titel
Hyaluronic acid-coated liposome for active targeting on CD44 expressing tumors
verfasst von
Zhenfen Tian
Jianwen Liu
Na Li
Vasil M. Garamus
Aihua Zou
Publikationsdatum
01.09.2018
Verlag
Springer Netherlands
Erschienen in
Journal of Nanoparticle Research / Ausgabe 9/2018
Print ISSN: 1388-0764
Elektronische ISSN: 1572-896X
DOI
https://doi.org/10.1007/s11051-018-4324-1

Weitere Artikel der Ausgabe 9/2018

Journal of Nanoparticle Research 9/2018 Zur Ausgabe

    Marktübersichten

    Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.